CLINICAL TRIALS PROFILE FOR RHINOCORT

505(b)(2) Clinical Trials for Rhinocort

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials

Trial Type	Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
New Formulation	NCT00641979 ↗	New Nasal Applicator / New Formulation - User Study	Completed	AstraZeneca	Phase 2	2002-04-01	The purpose of this study is to compare the efficacy of once daily dosing with Rhinocort Aqua (new formulation) against Rhinocort Aqua (current formulation) and placebo in reliving the symptoms of seasonal allergic rhinitis (SAR).

All Clinical Trials for Rhinocort

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00560586 ↗	Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome	Completed	University of Louisville	Phase 4	2004-04-01	-Intranasal budesonide therapy may lead to improved symptoms and sleep study findings in children with mild obstructive sleep apnea with and without allergic rhinitis that would not be treated with T&A. The aim of the study is to conduct a randomized double blind cross-over trial comparing the effect of once a day intranasal budesonide therapy vs. placebo in children with mild sleep apnea that would not be candidates for T&A.
NCT00641212 ↗	Children, Perennial Allergic Rhinitis (PAR), l-t Growth	Completed	AstraZeneca	Phase 4	2000-01-01	The purpose of this study is to compare the effect of Rhinocort nasal spray with placebo on growth in children with perennial allergic rhinitis over 12 months.
NCT00641680 ↗	Rhinocort Aqua Versus Placebo and Fluticasone Propionate	Completed	AstraZeneca	Phase 3	2003-04-01	The purpose of this study is to compare once daily treatment with Rhinocort against placebo and Fluticasone Propionate at reliving the nasal symptoms of seasonal allergic rhinitis.

Clinical Trial Conditions for Rhinocort

Condition Name

Condition Name for Rhinocort
Intervention	Trials
Seasonal Allergic Rhinitis	4
Allergic Rhinitis	2
Perennial Allergic Rhinitis	1

Condition MeSH

Condition MeSH for Rhinocort
Intervention	Trials
Rhinitis	9
Rhinitis, Allergic	7
Rhinitis, Allergic, Seasonal	5

Clinical Trial Locations for Rhinocort

Trials by Country

Trials by Country for Rhinocort
Location	Trials
China	3
Canada	3
United States	2
Thailand	1
Austria	1

Trials by US State

Trials by US State for Rhinocort
Location	Trials
North Carolina	1
Kentucky	1

Clinical Trial Progress for Rhinocort

Clinical Trial Phase

Clinical Trial Phase for Rhinocort
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	3
Phase 2	5

Clinical Trial Status

Clinical Trial Status for Rhinocort
Clinical Trial Phase	Trials
Completed	10
Recruiting	1
Withdrawn	1

Clinical Trial Sponsors for Rhinocort

Sponsor Name

Sponsor Name for Rhinocort
Sponsor	Trials
AstraZeneca	4
Ligand Pharmaceuticals	2
National Cancer Institute (NCI)	1

Sponsor Type

Sponsor Type for Rhinocort
Sponsor	Trials
Industry	10
Other	5
NIH	1